BRAVATO (ex-V3SWG)

Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO; ex-V3SWG)   In recognition of the increasing importance of viral vectors for the development of new vaccines and the need to understand their associated…

Continue Reading

SPEAC

Safety Platform for Emergency vACcines (SPEAC)   The Coalition for Epidemic Preparedness Innovations (CEPI) mission is to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access…

Continue Reading

GAIA

Global Alignment of Immunization Safety Assessment in Pregnancy (GAIA) Immunization in pregnancy is a promising public health strategy to reduce illness and death among pregnant women and young infants. This…

Continue Reading

SOMNIA

Systematic Observational Method for Narcolepsy and Influenza Immunization Assessment (SOMNIA) Background: In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza…

Continue Reading

GRiP

Global Research in Paediatrics (GRiP) Randomised controlled trials (RCTs) are considered the gold standard for assessing the efficacy of drugs prior to their approval for use in the general population…

Continue Reading

V3SWG

The Brighton Collaboration (BC) Viral Vector Vaccines Safety Working Group (V3SWG) was renamed to Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) in July of 2020, so as to expand beyond…

Continue Reading
Close Menu